Bioxcel Therapeutics (BTAI)
$2.84
Bioxcel Therapeutics (BTAI) Share Price Forecast
Currently 16 wall-street analysts regularly analyze the financials of Bioxcel Therapeutics on a frequent basis to provide recommendations along with target share price. 16 analysts offering 12-month price forecasts for Bioxcel Therapeutics (BTAI) have a share price target of $19.5. This median of share price forecast represents a 586.62% upside from the latest price of $2.84 as on 28.09.23.
Bioxcel Therapeutics (BTAI) Price vs Consensus Price Target
Price
Target Price
As per the chart shown above, analysts believe that the Bioxcel Therapeutics (BTAI) share price will touch around $19.5 in next 12-months.
Bioxcel Therapeutics (BTAI) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Bioxcel Therapeutics's share price and its median forecast price. As on 28.09.23, the difference is -80.36%
Bioxcel Therapeutics (BTAI): Difference between Current Price & Median Forecasted Price
Difference in Percentage terms
Bioxcel Therapeutics (BTAI) Share Price : Analyst Recommendation
Based on 16 analysts tracking and researching Bioxcel Therapeutics (BTAI) share have buy recommendation on an average.
| 3M Ago | 1M Ago | Current | |
| Buy | 8 | 8 | 8 |
| Outperform | 5 | 5 | 5 |
| Hold | 3 | 3 | 3 |
| Underperform | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
Bioxcel Therapeutics (BTAI) Share Price Technical Analysis
50 Day Moving Average v/s Current Share Price
Moving Average
Price
200 Day Moving Average v/s Current Share Price
Moving Average
Price
FAQs
The latest share price target for Bioxcel Therapeutics (BTAI) is $19.5, offered by 16 analysts offering 12-month price forecasts.
Bioxcel Therapeutics (BTAI) has a maximum of 5.87 upside potential, based on 16 analysts offering 12-month price forecasts.
Based on 16 analysts tracking and researching Bioxcel Therapeutics (BTAI), 81.25% have a buy recommendation. Remaining 18.75% have either sell or hold recommendations.
The latest share price of Bioxcel Therapeutics (BTAI) is $2.84 as of 28/09/2023.
13 of total 16 analysts offering stock ratings for Bioxcel Therapeutics BTAI have recommended buy rating.
₹0 US Stocks a/c Opening Fee